← Therapeutics
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry
São Paulo topical lidocaine tinnitus study
Also known as: Topical lidocaine tinnitus study, Lidocaine 10 MG/ML
Institution-led study
Sponsor / Institution
Institution-led study
Program Type
Therapeutic
Modality
Small Molecule
Stage
Not applicable
Status
Completed
Target Gene
—
Route / Mode
Topical intra-auricular application
Confidence
88%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
Brazil
Population
adult, tinnitus
Trial IDs
1
Mechanism
Randomized crossover study testing whether intra-auricular topical 10% lidocaine reduced subjective tinnitus intensity versus distilled-water placebo.
Indications
Notes
Registry-verified academic placebo-controlled study of topical lidocaine for tinnitus. This remains a study-level therapeutic record, not a current commercial hearing-loss product.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...
IDs: NCT05711641
Key Events
2022-09-02
2023-06-01
Clinical Trials (1)
Data Checks
institution-led-studyregistry-only-evidencemerged-generated-intervention-armsplacebo-arm-collapsedstudy-level-not-standalone-productnot-confirmed-current-product
Related Programs
PEDMARK by Fennec Pharmaceuticals
Company: Fennec Pharmaceuticals · Small Molecule · Marketed
SENS-401 (Arazasetron) by Sensorion
Company: Sensorion · Small Molecule · Phase 2
AC102 by AudioCure Pharma
Company: AudioCure Pharma · Small Molecule · Phase 2
SPI-1005 by Sound Pharmaceuticals
Company: Sound Pharmaceuticals · Small Molecule · Phase 3
ACOU085 by Acousia Therapeutics
Company: Acousia Therapeutics GmbH · Small Molecule · Phase 2
CIL001 (Paliroden) by Cilcare
Company: Cilcare SAS · Small Molecule · Phase 1/2